Brief: SkinBioTherapeutics Says CEO Stuart Ashman Resigns After Suspension
13/02/2026 07:12
Feb 13 (Reuters) - SkinBioTherapeutics PLC SBTX.L: SKINBIOTHERAPEUTICS PLC - CEO STUART ASHMAN RESIGNS AFTER SUSPENSION SKINBIOTHERAPEUTICS PLC - MARTIN HUNT ASSUMES ROLE OF EXECUTIVE CHAIRMAN TEMPORARILY SKINBIOTHERAPEUTICS PLC - COMPANY SEARCHING FOR INTERIM AND PERMANENT CEO Source text: ID:nRSM8564Sa Further company coverage: SBTX.L ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Skinbiotherapeutics
See all newsBrief: SkinBioTherapeutics Appoints Rachel Parsonage As CEO & Alyson Levett As Chair On Permanent Basis
SkinBioTherapeutics - Trading Statement
Brief: SkinBioTherapeutics Appoints Anita Slater To Start As Interim CFO
SkinBioTherapeutics - Appointment of Interim CFO
SkinBioTherapeutics - Holding(s) in Company